Breast Cancer Computer-Aided Detection
Empower Your Medical Practice with Advanced Technology
QuData's AI-powered system enhances the accuracy of breast cancer detection, reducing the likelihood of missed diagnoses and false positives. This enables early detection and intervention while providing a reliable second expert opinion for medical practitioners. Our approach also achieves cost-efficiency by minimizing unnecessary medical procedures and reducing associated healthcare costs.
Recognized for its impact, this project received a grant from the Seeds of Bravery program to support further development of AI in diagnostics.
Key Features: What Makes Our Solution Stand Out
Enhanced Diagnostic Accuracy
- Offers unparalleled precision in breast cancer detection.
- Reduces the likelihood of missed diagnoses and false positives.
Early Detection and Intervention
- Identifies breast cancer at its earliest stages, leading to more effective treatments.
- Increases the chances of full recovery and improved patient outcomes.
Second Expert Opinion
- Serves as a reliable second expert opinion for medical practitioners.
- Provides additional insights and confirmation in complex or challenging cases.
Educational Platform
- Empowers medical students and professionals to enhance their diagnostic skills.
- Offers a learning environment with access to real-world medical cases and expert guidance.
Cost-Efficiency
- Minimizes unnecessary medical procedures and treatments.
- Reduces healthcare costs associated with diagnostic testing
From Data to Diagnosis: How it Works
Making a Difference:
State-of-the-art Accuracy
We have achieved a significant accuracy level of 0.8 for the F1‑score. This metric combines precision and recall into a single measure. The F1‑score is calculated as the harmonic mean when evaluating the 5‑class BI-RADS level classification and the 4‑class Density classification.
Qudata's Solution Wins EU Grant
Computer-Aided Technology for Early Breast Cancer Detection by QuData was selected for the Seeds of Bravery program, funded by the European Union under the European Innovation Council (EIC). As part of the UASEEDs Deep Tech Scale-up and Acceleration Open Call, QuData’s technology received a grant to support its development.
Our project has been recognized with the Seal of Excellence under the UASEEDs grant program. This prestigious badge highlights QuData’s commitment to innovation and the potential impact of our AI-driven technology to enhance early breast cancer detection and improve patient outcomes.
Technical Details: Integration & Security
Access detailed technical specifications and security protocols for Breast Cancer Computer-Aided Detection by QuData. Learn how to seamlessly integrate the QuData’s service for AI-powered mammography analysis with PACS systems to enhance medical image processing while ensuring security and efficiency.
OPEN DOCUMENTFrequently Asked Questions
It is an AI-powered service from QuData’s QuMed initiative that analyzes mammograms and assigns a BI-RADS category to each image. It helps radiologists detect breast abnormalities earlier, reduces missed diagnoses and false positives, and provides a second expert opinion.
QuData is an AI and machine learning company. QuMed is QuData’s dedicated initiative for applying artificial intelligence in medicine. It develops AI-driven solutions for medical image analysis, diagnostic support and workflow optimization in healthcare institutions, including the breast cancer computer-aided detection service described on this page.
Mammograms taken in a clinic or hospital are sent to the AI system, which preprocesses and segments the image and classifies it with convolutional neural networks. The system assigns a BI-RADS category to each view and marks suspicious areas with bounding boxes and class activation maps (Grad-CAM). These highlight findings such as masses and calcifications, and the result is returned as a structured report for the radiologist to review.
BI-RADS (Breast Imaging-Reporting and Data System) is the standard scale for reporting mammography findings. The model classifies images into BI-RADS 1 (negative), 2 (benign findings), 3 (probably benign), 4 (suspicious abnormality) and 5 (highly suggestive of malignancy). It also classifies breast density into 4 classes.
The current model reaches an overall accuracy of more than 80%.
No. The service is a decision-support tool. It provides a second opinion, helps prioritize urgent cases, and reduces time spent on routine mammogram reviews, while the final diagnosis remains the responsibility of a qualified medical professional.
Diagnostic centers, mammography clinics, multispecialty hospitals with radiology departments, oncology centers and private practices with mammography equipment.
Radiologists use it for second opinions; junior radiologists and students use it as a training tool; and it supports telemedicine for remote or underserved regions.
Yes. QuData’s AI-powered mammography analysis solution is designed to integrate with existing medical imaging workflows through PACS (Picture Archiving and Communication System) and the DICOM protocol (Digital Imaging and Communications in Medicine).
It works with equipment from different manufacturers. The average processing time is 10-15 seconds per image, and the system scales automatically with the number of simultaneous requests.
Data in transit is encrypted over HTTPS and DICOM images are stored with AES-256 encryption on a secure cloud platform. After you retrieve your results, the images are deleted from QuData’s servers. If they are not retrieved, they are deleted automatically within 24 hours. The service is built to meet HIPAA and GDPR requirements.
Yes. Sign up for a free trial on the QuMed platform to upload mammograms and see BI-RADS results with highlighted findings. For integration and security details, see the service documentation.